Effects of ?-3 polyunsaturated fatty acid supplementation in the treatment of adolescents with depressive disorder

Not Applicable

• Conditions: Depressive disorder; Mental and Behavioural Disorders; Depressive episode, unspecified

• Registration Number: ISRCTN68038781
• Lead Sponsor: Shanghai Jiao Tong University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-12
• Last Update Posted: 12 September 2022
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Current inclusion criteria as of 30/08/2022:
1. Meet the diagnostic criteria of International Classification of Diseases (ICD-10) for depressive disorder
2. Aged 13-24 years
3. Never received antidepressant medication, or have not received antidepressant medication within 2 weeks
4. The patient's family members or legal guardians fully understood the content of this study and signed informed consent
_____

Previous inclusion criteria:
1. The diagnostic criteria of International Classification of Diseases (ICD-10) for depressive disorder
2. 14-25 years old
3. Never received antidepressant medication, or have not received antidepressant medication within 2 weeks
4. The patient's family members or legal guardians fully understood the content of this study and signed informed consent

Exclusion Criteria

1. People diagnosed with bipolar disorder or other according to the ICD-10
2. A recent or past history of alcohol and drug dependence, other psychiatric disorders, eating disorders or mental retardation
3. Serious or chronic physical disease, endocrine disease or organic brain diseases
4. Regular consumption of ?-3 PUFA supplements or eating fish equal to or more than 4 times per week
5. Conducting additional clinical trials within 4 weeks prior to the start of this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified